Literature DB >> 8298713

Chronic meningococcemia in a child with a deficiency of the sixth component of complement.

M B Fasano1, K Sullivan, L Ibsen, J A Winkelstein.   

Abstract

Chronic meningococcemia represents an uncommon manifestation of meningococcal disease. Microbial and host factors which may predispose to this form of meningococcal disease are not understood. Although acute meningococcal disease is frequently found in patients with terminal complement deficiencies, the relationship of chronic meningococcemia to complement deficiencies is unclear. We present a case report and a review of the literature describing chronic meningococcemia in association with deficiencies of the complement system. A total of eight cases were identified, all of whom were male. Six of the eight patients were children and two of the eight had a previous history of meningococcal disease. This case report, in conjunction with the previously reported cases, suggests an association between complement deficiencies and chronic meningococcemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298713     DOI: 10.1111/j.1399-3038.1993.tb00094.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  4 in total

1.  Endotoxin release and cytokine production in acute and chronic meningococcaemia.

Authors:  J M Prins; F N Lauw; B H Derkx; P Speelman; E J Kuijper; J Dankert; S J van Deventer
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

2.  Chronic meningococcemia presenting with recurrent painful rash and poly-arthralgia without fever.

Authors:  C Delwaide; P De Leeuw; A François; P Beckers; V Hennaux; Ph Lefèvre
Journal:  IDCases       Date:  2018-06-30

3.  Chronic meningococcemia in a 16-year-old boy: a case report.

Authors:  Solen Kernéis; Emmanuel Mahé; Beate Heym; Valérie Sivadon-Tardy; Françoise Bourgeois; Thomas Hanslik
Journal:  Cases J       Date:  2009-07-31

Review 4.  Recurrent Fever in Children.

Authors:  Sofia Torreggiani; Giovanni Filocamo; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2016-03-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.